A detailed history of Deutsche Bank Ag\ transactions in Generation Bio Co. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,251,566 shares of GBIO stock, worth $3.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,251,566
Previous 1,232,316 1.56%
Holding current value
$3.53 Million
Previous $2.03 Million 150.52%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.73 - $4.07 $33,302 - $78,347
19,250 Added 1.56%
1,251,566 $5.09 Million
Q4 2023

Feb 14, 2024

BUY
$0.91 - $3.35 $1.1 Million - $4.06 Million
1,213,116 Added 6318.31%
1,232,316 $2.03 Million
Q2 2023

Aug 14, 2023

SELL
$3.5 - $5.67 $34,919 - $56,569
-9,977 Reduced 34.19%
19,200 $105,000
Q1 2023

May 15, 2023

SELL
$3.61 - $7.01 $437,196 - $848,960
-121,107 Reduced 80.59%
29,177 $125,000
Q4 2022

Feb 13, 2023

BUY
$3.66 - $6.77 $37,804 - $69,927
10,329 Added 7.38%
150,284 $590,000
Q3 2022

Nov 14, 2022

SELL
$4.68 - $8.34 $38,567 - $68,729
-8,241 Reduced 5.56%
139,955 $743,000
Q2 2022

Aug 11, 2022

SELL
$4.87 - $9.41 $21,330 - $41,215
-4,380 Reduced 2.87%
148,196 $973,000
Q1 2022

May 13, 2022

BUY
$4.16 - $7.76 $915 - $1,707
220 Added 0.14%
152,576 $1.12 Million
Q4 2021

Feb 11, 2022

SELL
$5.99 - $24.97 $30,009 - $125,099
-5,010 Reduced 3.18%
152,356 $1.08 Million
Q3 2021

Nov 04, 2021

BUY
$20.0 - $27.43 $1,740 - $2,386
87 Added 0.06%
157,366 $3.95 Million
Q2 2021

Aug 11, 2021

BUY
$24.34 - $38.34 $228,917 - $360,587
9,405 Added 6.36%
157,279 $4.23 Million
Q1 2021

May 13, 2021

BUY
$24.74 - $40.2 $3.44 Million - $5.58 Million
138,861 Added 1540.67%
147,874 $4.21 Million
Q4 2020

Feb 16, 2021

BUY
$21.68 - $51.61 $53,267 - $126,805
2,457 Added 37.48%
9,013 $255,000
Q3 2020

Nov 12, 2020

BUY
$18.07 - $31.84 $118,466 - $208,743
6,556 New
6,556 $202,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $166M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.